SCHEMBL30220173

SCHEMBL30220173

CCCCCCCCCCOC(=O)Oc1c(F)c(F)c(F)c(F)c1F

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 1/20 0.48
EPHX1 P07099 1/20 0.46
TSHR P16473 4/20 0.45
ALDH1A1 P00352 2/20 0.45
LMNA P02545 1/20 0.45
ESR1 P03372 2/20 0.44
TP53 P04637 1/20 0.42
CYP3A4 P08684 1/20 0.42
MAPK1 P28482 1/20 0.42
HCAR2 Q8TDS4 1/20 0.42
RAD52 P43351 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
NPC1 O15118 1/20 0.41
MAPT P10636 1/20 0.41
RAB9A P51151 1/20 0.41
AKR1C4 P17516 1/20 0.41
AKR1C3 P42330 1/20 0.41
AKR1C2 P52895 1/20 0.41
AKR1C1 Q04828 1/20 0.41
FAAH O00519 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16838222 0.93 RECQL (0.38) NAAAEPHX1TSHRALDH1A1LMNA
SCHEMBL20695794 0.78 TSHR (0.57) TSHRALDH1A1LMNATP53CYP3A4
SCHEMBL19583356 0.78 TSHR (0.57) TSHRALDH1A1LMNATP53CYP3A4
SCHEMBL19583397 0.78 TSHR (0.57) TSHRALDH1A1LMNATP53CYP3A4
SCHEMBL20695795 0.78 TSHR (0.57) TSHRALDH1A1LMNATP53CYP3A4
SCHEMBL1837444 0.78 NAAA (0.67) NAAAEPHX1TSHRALDH1A1LMNA
SCHEMBL1839030 0.78 NAAA (0.67) NAAAEPHX1TSHRALDH1A1LMNA
SCHEMBL1838958 0.78 NAAA (0.67) NAAAEPHX1TSHRALDH1A1LMNA
SCHEMBL1839498 0.78 NAAA (0.67) NAAAEPHX1TSHRALDH1A1LMNA
SCHEMBL1834574 0.78 NAAA (0.67) NAAAEPHX1TSHRALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112513039-B TLR7 agonist prodrug, preparation method thereof and application thereof in medicine 江苏恒瑞医药股份有限公司 2023-01-24 CN disclosed